Plans designed specifically for disabled dual-eligible Medicare and Medicaid beneficiaries are not necessarily enough to reduce use of costly services, according to a new report from the Government Accountability Office.
Plans designed specifically for disabled dual-eligible Medicare and Medicaid beneficiaries are not necessarily enough to reduce use of costly services, according to a new report from the Government Accountability Office (GAO).
In 2009, Medicare and Medicaid spent $103 billion on individuals who are disabled, under age 65, and qualify for both Medicare and Medicaid, according to the GAO report. Dual-eligible beneficiaries accounted for less than one-fifth of each program’s population, but one-third of each program’s spending.
Even though states with high Medicaid spending often had lower Medicare spending, they nearly always had greater overall spending for beneficiaries, the investigators found.
While both disabled and aged dual-eligible beneficiaries had moderately better health outcomes performance, dual-eligible special needs plans (D-SNPs) actually had similar levels of costly Medicare-covered services, like readmissions and emergency room visits.
“…D-SNPs’ moderately better performance on health outcome measures did not translate into lower utilization levels of costly Medicare services for either all disabled dual-eligible beneficiaries or those with 6 or more chronic conditions,” the authors wrote.
Those in D-SNPs did have slightly higher levels of emergency room use. As the number of chronic and mental health conditions increased, so did the average number of emergency room visits, inpatient stays, and readmissions, according to the report.
The authors found that beneficiaries with high Medicare expenditures were more likely than those with high Medicaid expenditures to have multiple chronic or mental health conditions. Roughly a third of beneficiaries that fell into the former category had 6 or more chronic conditions compared with 14% of the latter. Plus, a quarter of beneficiaries with high Medicare expenditures had 3 or more mental health conditions compared with 13% of the Medicaid equivalents.
“Whether CMS and participating states will be able to improve quality without increasing overall program spending for disabled dual-eligible beneficiaries is uncertain,” the authors concluded.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More